{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:25:16Z","timestamp":1792113916818,"version":"4.4.0"},"reference-count":158,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/501100002322","name":"CAPES, Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"FAPERJ, Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["SEI-260003\/007043\/2022"],"award-info":[{"award-number":["SEI-260003\/007043\/2022"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"FAPERJ, Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["SEI-260003\/003788\/2022"],"award-info":[{"award-number":["SEI-260003\/003788\/2022"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"FAPERJ, Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/010.002270\/2019"],"award-info":[{"award-number":["E-26\/010.002270\/2019"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>COVID-19, an airborne disease caused by a betacoronavirus named SARS--\nCoV-2, was officially declared a pandemic in early 2020, resulting in more than 770 million\nconfirmed cases and over 6.9 million deaths by September 2023. Although the introduction\nof vaccines in late 2020 helped reduce the number of deaths, the global effort to\nfight COVID-19 is far from over. While significant progress has been made in a short period,\nthe fight against SARS-CoV-2\/COVID-19 and other potential pandemic threats\ncontinues. Like AIDS and hepatitis C epidemics, controlling the spread of COVID-19\nwill require the development of multiple drugs to weaken the virus's resistance to different\ndrug treatments. Therefore, it is essential to continue developing new drug candidates\nderived from natural or synthetic small molecules. Coumarins are a promising\ndrug design and development scaffold due to their synthetic versatility and unique physicochemical\nproperties. Numerous examples reported in scientific literature, mainly by &lt;i&gt;in\nsilico&lt;\/i&gt; prospection, demonstrate their potential contribution to the rapid development of\ndrugs against SARS-CoV-2\/COVID-19 and other emergent and reemergent viruses.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0109298673285609231220111556","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T05:04:32Z","timestamp":1705813472000},"page":"539-562","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Natural and Synthetic Coumarins as Potential Drug Candidates against SARS-CoV-2\/COVID-19"],"prefix":"10.2174","volume":"32","author":[{"given":"Iara","family":"da Silva Santos","sequence":"first","affiliation":[{"name":"Department of Organic Chemistry, Instituto de Pesquisas de Produtos Naturais Walter Mors, Universidade\nFederal do Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia Oliveira","family":"Magalhaes","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Universidade Federal\ndo Rio de Janeiro, Instituto de Qu\u00edmica, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1430-2566","authenticated-orcid":true,"given":"Roberta Katlen Fusco","family":"Marra","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Universidade Federal\ndo Rio de Janeiro, Instituto de Qu\u00edmica, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5579-7809","authenticated-orcid":true,"given":"Camilo Henrique","family":"da Silva Lima","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Universidade Federal\ndo Rio de Janeiro, Instituto de Qu\u00edmica, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5807-6161","authenticated-orcid":true,"given":"Lidilhone","family":"Hamerski","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Instituto de Pesquisas de Produtos Naturais Walter Mors, Universidade\nFederal do Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1558-0928","authenticated-orcid":true,"given":"Magaly Girao","family":"Albuquerque","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Universidade Federal\ndo Rio de Janeiro, Instituto de Qu\u00edmica, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3020-9310","authenticated-orcid":true,"given":"Barbara Vasconcellos","family":"da Silva","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Universidade Federal\ndo Rio de Janeiro, Instituto de Qu\u00edmica, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3390\/molecules26020448","volume":"26","author":"Vougogiannopoulou K.","year":"2021","unstructured":"Vougogiannopoulou K.; Corona A.; Tramontano E.; Alexis M.N.; Skaltsounis A.L.; Natural and nature-derived products targeting human coronaviruses. Molecules  2021,26(2),448","journal-title":"Molecules"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1086\/420743","volume":"38","author":"Christian M.D.","year":"2004","unstructured":"Christian M.D.; Poutanen S.M.; Loutfy M.R.; Muller M.P.; Low D.E.; Severe acute respiratory syndrome. Clin Infect Dis  2004,38(10),1420-1427","journal-title":"Clin Infect Dis"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.cell.2020.09.018","volume":"183","author":"Yao H.","year":"2020","unstructured":"Yao H.; Song Y.; Chen Y.; Wu N.; Xu J.; Sun C.; Zhang J.; Weng T.; Zhang Z.; Wu Z.; Cheng L.; Shi D.; Lu X.; Lei J.; Crispin M.; Shi Y.; Li L.; Li S.; Molecular architecture of the SARS-CoV-2 virus. Cell  2020,183(3),730-738.e13","journal-title":"Cell"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4103\/jfmpc.jfmpc_839_21","volume":"11","author":"Pustake M.","year":"2022","unstructured":"Pustake M.; Tambolkar I.; Giri P.; Gandhi C.; SARS, MERS and COVID-19: An overview and comparison of clinical, laboratory and radiological features. J Family Med Prim Care  2022,11(1),10-17","journal-title":"J Family Med Prim Care"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"Huang C.","year":"2020","unstructured":"Huang C.; Wang Y.; Li X.; Ren L.; Zhao J.; Hu Y.; Zhang L.; Fan G.; Xu J.; Gu X.; Cheng Z.; Yu T.; Xia J.; Wei Y.; Wu W.; Xie X.; Yin W.; Li H.; Liu M.; Xiao Y.; Gao H.; Guo L.; Xie J.; Wang G.; Jiang R.; Gao Z.; Jin Q.; Wang J.; Cao B.; Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet  2020,395(10223),497-506","journal-title":"Lancet"},{"key":"ref=6","unstructured":"WHO 2019.   Available from:  https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"14066","DOI":"10.1021\/acs.chemrev.1c01062","volume":"122","author":"Saville J.W.","year":"2022","unstructured":"Saville J.W.; Berezuk A.M.; Srivastava S.S.; Subramaniam S.; Three-dimensional visualization of viral structure, entry, and replication underlying the spread of SARS-CoV-2. Chem Rev  2022,122(17),14066-14084","journal-title":"Chem Rev"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"11287","DOI":"10.1021\/acs.chemrev.1c00965","volume":"122","author":"Gao K.","year":"2022","unstructured":"Gao K.; Wang R.; Chen J.; Cheng L.; Frishcosy J.; Huzumi Y.; Qiu Y.; Schluckbier T.; Wei X.; Wei G.W.; Methodology-centered review of molecular modeling, simulation, and prediction of SARS-CoV-2. Chem Rev  2022,122(13),11287-11368","journal-title":"Chem Rev"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"113977","DOI":"10.1016\/j.biopha.2022.113977","volume":"157","author":"Abulsoud A.I.","year":"2023","unstructured":"Abulsoud A.I.; El-Husseiny H.M.; El-Husseiny A.A.; El-Mahdy H.A.; Ismail A.; Elkhawaga S.Y.; Khidr E.G.; Fathi D.; Mady E.A.; Najda A.; Algahtani M.; Theyab A.; Alsharif K.F.; Albrakati A.; Bayram R.; Abdel-Daim M.M.; Doghish A.S.; Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions. Biomed Pharmacother  2023,157,113977","journal-title":"Biomed Pharmacother"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.tim.2018.04.004","volume":"26","author":"Mercorelli B.","year":"2018","unstructured":"Mercorelli B.; Pal&#xF9; G.; Loregian A.; Drug repurposing for viral infectious diseases: How far are we? Trends Microbiol  2018,26(10),865-876","journal-title":"Trends Microbiol"},{"key":"ref=11","year":"2020","unstructured":"NIH Available from:  https:\/\/www.COVID19treatmentguidelines.nih.gov\/therapies\/antivirals-including-antibody-products\/chloroquine-or-hydroxychloroquine-and-or-azithromycin\/2020"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cmi.2020.08.022","volume":"27","author":"Fiolet T.","year":"2021","unstructured":"Fiolet T.; Guihur A.; Rebeaud M.E.; Mulot M.; Peiffer-Smadja N.; Mahamat-Saleh Y.; Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis. Clin Microbiol Infect  2021,27(1),19-27","journal-title":"Clin Microbiol Infect"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/jac\/dkab404","volume":"77","author":"Ayerbe L.","year":"2022","unstructured":"Ayerbe L.; Risco-Risco C.; Forgnone I.; P&#xE9;rez-Pi&#xF1;ar M.; Ayis S.; Azithromycin in patients with COVID-19: A systematic review and meta-analysis. J Antimicrob Chemother  2022,77(2),303-309","journal-title":"J Antimicrob Chemother"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2147\/TCRM.S301817","volume":"17","author":"Saghir S.A.M.","year":"2021","unstructured":"Saghir S.A.M.; AlGabri N.A.; Alagawany M.M.; Attia Y.A.; Alyileili S.R.; Elnesr S.S.; Shafi M.E.; Al-shargi O.Y.A.; Al-balagi N.; Alwajeeh A.S.; Alsalahi O.S.A.; Patra A.K.; Khafaga A.F.; Negida A.; Noreldin A.; Al-Amarat W.; Almaiman A.A.; El-Tarabily K.A.; Abd El-Hack M.E.; Chloroquine and hydroxychloroquine for the prevention and treatment of COVID-19: A fiction, hope or hype? an updated review. Ther Clin Risk Manag  2021,17,371-387","journal-title":"Ther Clin Risk Manag"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"6571","DOI":"10.1007\/s00253-016-7660-z","volume":"100","author":"Costa T.M.","year":"2016","unstructured":"Costa T.M.; Tavares L.B.B.; de Oliveira D.; Fungi as a source of natural coumarins production. Appl Microbiol Biotechnol  2016,100(15),6571-6584","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"173644","DOI":"10.1016\/j.ejphar.2020.173644","volume":"889","author":"Stasi C.","year":"2020","unstructured":"Stasi C.; Fallani S.; Voller F.; Silvestri C.; Treatment for COVID-19: An overview. Eur J Pharmacol  2020,889,173644","journal-title":"Eur J Pharmacol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1159363","DOI":"10.3389\/fphar.2023.1159363","volume":"14","author":"Makarem A.","year":"2023","unstructured":"Makarem A.; Zareef R.; Abourjeili J.; Nassar J.E.; Bitar F.; Arabi M.; Low molecular weight heparin in COVID-19: Benefits and concerns. Front Pharmacol  2023,14,1159363","journal-title":"Front Pharmacol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"173854","DOI":"10.1016\/j.ejphar.2021.173854","volume":"894","author":"Noreen S.","year":"2021","unstructured":"Noreen S.; Maqbool I.; Madni A.; Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic. Eur J Pharmacol  2021,894,173854","journal-title":"Eur J Pharmacol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"7095","DOI":"10.1128\/JVI.79.11.7095-7103.2005","volume":"79","author":"Chen L.","year":"2005","unstructured":"Chen L.; Gui C.; Luo X.; Yang Q.; G&#xFC;nther S.; Scandella E.; Drosten C.; Bai D.; He X.; Ludewig B.; Chen J.; Luo H.; Yang Y.; Yang Y.; Zou J.; Thiel V.; Chen K.; Shen J.; Shen X.; Jiang H.; Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J Virol  2005,79(11),7095-7103","journal-title":"J Virol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"8562","DOI":"10.3390\/molecules27238562","volume":"27","author":"Ceramella J.","year":"2022","unstructured":"Ceramella J.; Iacopetta D.; Sinicropi M.S.; Andreu I.; Mariconda A.; Saturnino C.; Giuzio F.; Longo P.; Aquaro S.; Catalano A.; Drugs for COVID-19: An update. Molecules  2022,27(23),8562","journal-title":"Molecules"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41533-022-00300-z","volume":"32","author":"Kushner P.","year":"2022","unstructured":"Kushner P.; McCarberg B.H.; Grange L.; Kolosov A.; Haveric A.L.; Zucal V.; Petruschke R.; Bissonnette S.; The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19. NPJ Prim Care Respir Med  2022,32(1),35","journal-title":"NPJ Prim Care Respir Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3390\/v14061345","volume":"14","author":"Yip A.J.W.","year":"2022","unstructured":"Yip A.J.W.; Low Z.Y.; Chow V.T.K.; Lal S.K.; Repurposing molnupiravir for COVID-19: The mechanisms of antiviral activity. Viruses  2022,14(6),1345","journal-title":"Viruses"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"115292","DOI":"10.1016\/j.ejmech.2023.115292","volume":"252","author":"Bekheit M.S.","year":"2023","unstructured":"Bekheit M.S.; Panda S.S.; Girgis A.S.; Potential RNA-dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2. Eur J Med Chem  2023,252,115292","journal-title":"Eur J Med Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s00044-022-02951-6","volume":"31","author":"Joyce R.P.","year":"2022","unstructured":"Joyce R.P.; Hu V.W.; Wang J.; The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with ritonavir to reduce COVID-19-related hospitalizations. Med Chem Res  2022,31(10),1637-1646","journal-title":"Med Chem Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"9866","DOI":"10.3390\/ijms23179866","volume":"23","author":"Loos N.H.C.","year":"2022","unstructured":"Loos N.H.C.; Beijnen J.H.; Schinkel A.H.; The mechanism-based inactivation of CYP3A4 by Ritonavir: What mechanism? Int J Mol Sci  2022,23(17),9866","journal-title":"Int J Mol Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"140445","DOI":"10.1016\/j.bbapap.2020.140445","volume":"1868","author":"Breidenbach J.","year":"2020","unstructured":"Breidenbach J.; Bartz U.; G&#xFC;tschow M.; Coumarin as a structural component of substrates and probes for serine and cysteine proteases. Biochim Biophys Acta Proteins Proteomics  2020,1868(9),140445","journal-title":"Biochim Biophys Acta Proteins Proteomics"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.antiviral.2014.04.006","volume":"107","author":"Blaising J.","year":"2014","unstructured":"Blaising J.; Polyak S.J.; P&#xE9;cheur E.I.; Arbidol as a broad-spectrum antiviral: An update. Antiviral Res  2014,107,84-94","journal-title":"Antiviral Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/10.7326\/M21-4784","volume":"175","author":"Kaka A.S.","year":"2022","unstructured":"Kaka A.S.; MacDonald R.; Linskens E.J.; Langsetmo L.; Vela K.; Duan-Porter W.; Major update 2: Remdesivir for adults with COVID-19: A living systematic review and meta-analysis for the American college of physicians practice points. Ann Intern Med  2022,175(5),701-709","journal-title":"Ann Intern Med"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/biomedicines10020437","volume":"10","author":"Nappi F.","year":"2022","unstructured":"Nappi F.; Iervolino A.; Avtaar Singh S.S.; Molecular insights of SARS-CoV-2 antivirals administration: A balance between safety profiles and impact on cardiovascular phenotypes. Biomedicines  2022,10(2),437","journal-title":"Biomedicines"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3390\/ph14080736","volume":"14","author":"Gil Mart&#xED;nez V.","year":"2021","unstructured":"Gil Mart&#xED;nez V.; Avedillo Salas A.; Santander Ballest&#xED;n S.; Antiviral therapeutic approaches for SARS-CoV-2 infection: A systematic review. Pharmaceuticals  2021,14(8),736","journal-title":"Pharmaceuticals"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1080\/14787210.2023.2241638","volume":"21","author":"Navitha Reddy G.","year":"2023","unstructured":"Navitha Reddy G.; Jogvanshi A.; Naikwadi S.; Sonti R.; Nirmatrelvir and ritonavir combination: An antiviral therapy for COVID-19. Expert Rev Anti Infect Ther  2023,21(9),943-955","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"106870","DOI":"10.1016\/j.ijantimicag.2023.106870","volume":"62","author":"Tian F.","year":"2023","unstructured":"Tian F.; Feng Q.; Chen Z.; Efficacy and safety of molnupiravir treatment for COVID-19: A systematic review and meta-analysis of randomized controlled trials. Int J Antimicrob Agents  2023,62(2),106870","journal-title":"Int J Antimicrob Agents"},{"key":"ref=33","year":"2021","unstructured":"FDA Available from:  https:\/\/www.fda.gov\/consumers\/consumer-updates\/know-your-treatment-options-COVID-192021"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"4672","DOI":"10.3390\/jcm12144672","volume":"12","author":"Sixt T.","year":"2023","unstructured":"Sixt T.; Moretto F.; Esteve C.; Duong M.; Buisson M.; Mahy S.; Blot M.; Piroth L.; Healing treatments in COVID-19 patients: A narrative review. J Clin Med  2023,12(14),4672","journal-title":"J Clin Med"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/fcp.12889","volume":"37","author":"Yan D.","year":"2023","unstructured":"Yan D.; Yan B.; Viral target and metabolism-based rationale for combined use of recently authorized small molecule COVID-19 medicines: Molnupiravir, nirmatrelvir, and remdesivir. Fundam Clin Pharmacol  2023,37(4),726-738","journal-title":"Fundam Clin Pharmacol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/7355_2013_35","author":"Young R.J.","year":"2014","unstructured":"Young R.J.;  Physical properties in drug design  2014,1-68","journal-title":"Physical properties in drug design"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1136\/gutjnl-2014-309045","volume":"65","author":"Vercauteren K.","year":"2016","unstructured":"Vercauteren K.; Brown R.J.P.; Mesalam A.A.; Doerrbecker J.; Bhuju S.; Geffers R.; Van Den Eede N.; McClure C.P.; Troise F.; Verhoye L.; Baumert T.; Farhoudi A.; Cortese R.; Ball J.K.; Leroux-Roels G.; Pietschmann T.; Nicosia A.; Meuleman P.; Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice. Gut  2016,65(12),2029-2034","journal-title":"Gut"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s11684-017-0589-5","volume":"11","author":"Wang X.","year":"2017","unstructured":"Wang X.; Zou P.; Wu F.; Lu L.; Jiang S.; Development of small-molecule viral inhibitors targeting various stages of the life cycle of emerging and re-emerging viruses. Front Med  2017,11(4),449-461","journal-title":"Front Med"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1021\/acsinfecdis.0c00874","volume":"7","author":"Namchuk M.N.","year":"2021","unstructured":"Namchuk M.N.; Early returns on small molecule therapeutics for SARS-CoV-2. ACS Infect Dis  2021,7(6),1298-1302","journal-title":"ACS Infect Dis"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"9376","DOI":"10.1021\/acs.jmedchem.2c00636","volume":"65","author":"Pillaiyar T.","year":"2022","unstructured":"Pillaiyar T.; Flury P.; Kr&#xFC;ger N.; Su H.; Sch&#xE4;kel L.; Barbosa Da Silva E.; Eppler O.; Kronenberger T.; Nie T.; Luedtke S.; Rocha C.; Sylvester K.; Petry M.R.I.; McKerrow J.H.; Poso A.; P&#xF6;hlmann S.; G&#xFC;tschow M.; O\u2019Donoghue A.J.; Xu Y.; M&#xFC;ller C.E.; Laufer S.A.; Small-molecule thioesters as SARS-CoV-2 main protease inhibitors: Enzyme inhibition, structure\u2013activity relationships, antiviral activity, and X-ray structure determination. J Med Chem  2022,65(13),9376-9395","journal-title":"J Med Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s11427-020-1959-5","volume":"65","author":"Luo L.","year":"2022","unstructured":"Luo L.; Yang J.; Wang C.; Wu J.; Li Y.; Zhang X.; Li H.; Zhang H.; Zhou Y.; Lu A.; Chen S.; Natural products for infectious microbes and diseases: An overview of sources, compounds, and chemical diversities. Sci China Life Sci  2022,65(6),1123-1145","journal-title":"Sci China Life Sci"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"16711","DOI":"10.1039\/D1RA00644D","volume":"11","author":"Chakravarti R.","year":"2021","unstructured":"Chakravarti R.; Singh R.; Ghosh A.; Dey D.; Sharma P.; Velayutham R.; Roy S.; Ghosh D.; A review on potential of natural products in the management of COVID-19. RSC Advances  2021,11(27),16711-16735","journal-title":"RSC Advances"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3390\/molecules23020250","volume":"23","author":"Stefanachi A.","year":"2018","unstructured":"Stefanachi A.; Leonetti F.; Pisani L.; Catto M.; Carotti A.; Coumarin: A natural, privileged and versatile scaffold for bioactive compounds. Molecules  2018,23(2),250","journal-title":"Molecules"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.3390\/ijms21134618","volume":"21","author":"Annunziata F.","year":"2020","unstructured":"Annunziata F.; Pinna C.; Dallavalle S.; Tamborini L.; Pinto A.; An overview of coumarin as a versatile and readily accessible scaffold with broad-ranging biological activities. Int J Mol Sci  2020,21(13),4618","journal-title":"Int J Mol Sci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/andp.18200640205","volume":"64","author":"Vogel A.","year":"1820","unstructured":"Vogel A.; Darstellung von Benzoes&#xE4;ure aus der Tonka-Bohne und aus den Meliloten - oder Steinklee - Blumen.  Annalen der Physik und der physikalischen Chemie  1820,64(2),161-166","journal-title":"Annalen der Physik und der physikalischen Chemie"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1039\/JS8682100053","volume":"21","author":"Perkin W.H.","year":"1868","unstructured":"Perkin W.H.; VI.\u2014On the artificial production of coumarin and formation of its homologues. J Chem Soc  1868,21(0),53-63","journal-title":"J Chem Soc"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s10895-019-02446-5","volume":"29","author":"Kolbus A.","year":"2019","unstructured":"Kolbus A.; Danel A.; Grabka D.; Kucharek M.; Szary K.; Spectral properties of highly emissive derivative of coumarin with N,N-diethylamino, nitrile and tiophenecarbonyl moieties in water-methanol mixture. J Fluoresc  2019,29(6),1393-1399","journal-title":"J Fluoresc"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/cr60113a001","volume":"36","author":"Sethna S.M.","year":"1945","unstructured":"Sethna S.M.; Shah N.M.; The chemistry of coumarins. Chem Rev  1945,36(1),1-62","journal-title":"Chem Rev"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cbi.2016.05.001","volume":"254","author":"de Souza L.G.","year":"2016","unstructured":"de Souza L.G.; Renn&#xF3; M.N.; Figueroa-Villar J.D.; Coumarins as cholinesterase inhibitors: A review. Chem Biol Interact  2016,254,11-23","journal-title":"Chem Biol Interact"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3390\/foods9050645","volume":"9","author":"Lon&#x10D;ar M.","year":"2020","unstructured":"Lon&#x10D;ar M.; Jakovljevi\u0107 M.; \u0160ubari\u0107 D.; Pavli\u0107 M.; Buzjak Slu&#x17E;ek V.; Cindri\u0107 I.; Molnar M.; Coumarins in food and methods of their determination. Foods  2020,9(5),645","journal-title":"Foods"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6492346","volume":"2021","author":"Sharifi-Rad J.","year":"2021","unstructured":"Sharifi-Rad J.; Cruz-Martins N.; L&#xF3;pez-Jornet P.; Lopez E.P.F.; Harun N.; Yeskaliyeva B.; Beyatli A.; Sytar O.; Shaheen S.; Sharopov F.; Taheri Y.; Docea A.O.; Calina D.; Cho W.C.; Natural coumarins: Exploring the pharmacological complexity and underlying molecular mechanisms. Oxid Med Cell Longev  2021,2021,1-19","journal-title":"Oxid Med Cell Longev"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3390\/antibiotics11091156","volume":"11","author":"Tsivileva O.M.","year":"2022","unstructured":"Tsivileva O.M.; Koftin O.V.; Evseeva N.V.; Coumarins as fungal metabolites with potential medicinal properties. Antibiotics  2022,11(9),1156","journal-title":"Antibiotics"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.3389\/fmicb.2016.02170","volume":"7","author":"Kumar P.","year":"2017","unstructured":"Kumar P.; Mahato D.K.; Kamle M.; Mohanta T.K.; Kang S.G.; Aflatoxins: A global concern for food safety, human health and their management. Front Microbiol  2017,7,2170","journal-title":"Front Microbiol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.3390\/md12105160","volume":"12","author":"Prompanya C.","year":"2014","unstructured":"Prompanya C.; Dethoup T.; Bessa L.; Pinto M.; Gales L.; Costa P.; Silva A.; Kijjoa A.; New isocoumarin derivatives and meroterpenoids from the marine sponge-associated fungus Aspergillus similanensis sp. nov. KUFA 0013. Mar Drugs  2014,12(10),5160-5173","journal-title":"Mar Drugs"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S1074-5521(03)00051-6","volume":"10","author":"Eust&#xE1;quio A.S.","year":"2003","unstructured":"Eust&#xE1;quio A.S.; Gust B.; Luft T.; Li S.M.; Chater K.F.; Heide L.; Clorobiocin biosynthesis in Streptomyces: Identification of the halogenase and generation of structural analogs. Chem Biol  2003,10(3),279-288","journal-title":"Chem Biol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1590\/S0103-50532007000200030","volume":"18","author":"Lira S.P.","year":"2007","unstructured":"Lira S.P.; Seleghim M.H.R.; Williams D.E.; Marion F.; Hamill P.; Jean F.; Andersen R.J.; Hajdu E.; Berlinck R.G.S.; A SARS-coronovirus 3CL protease inhibitor isolated from the marine sponge Axinella cf. corrugata: structure elucidation and synthesis. J Braz Chem Soc  2007,18(2),440-443","journal-title":"J Braz Chem Soc"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/963248","volume":"2013","author":"Venugopala K.N.","year":"2013","unstructured":"Venugopala K.N.; Rashmi V.; Odhav B.; Review on natural coumarin lead compounds for their pharmacological activity. Bio Med Res Int  2013,2013,1-14","journal-title":"Bio Med Res Int"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s00253-018-8787-x","volume":"102","author":"Reen F.J.","year":"2018","unstructured":"Reen F.J.; Guti&#xE9;rrez-Barranquero J.A.; Parages M.L.; O&#xB4;Gara F.; Coumarin: A novel player in microbial quorum sensing and biofilm formation inhibition. Appl Microbiol Biotechnol  2018,102(5),2063-2073","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"174867","DOI":"10.1016\/j.ejphar.2022.174867","volume":"922","author":"Rostom B.","year":"2022","unstructured":"Rostom B.; Karaky R.; Kassab I.; Sylla-Iyarreta Veit&#xED;a M.; Coumarins derivatives and inflammation: Review of their effects on the inflammatory signaling pathways. Eur J Pharmacol  2022,922,174867","journal-title":"Eur J Pharmacol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1002\/slct.202101346","volume":"6","author":"Bouhaoui A.","year":"2021","unstructured":"Bouhaoui A.; Eddahmi M.; Dib M.; Khouili M.; Aires A.; Catto M.; Bouissane L.; Synthesis and biological properties of coumarin derivatives. A review. ChemistrySelect  2021,6(24),5848-5870","journal-title":"ChemistrySelect"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"113034","DOI":"10.1016\/j.ejmech.2020.113034","volume":"212","author":"Salehian F.","year":"2021","unstructured":"Salehian F.; Nadri H.; Jalili-Baleh L.; Youseftabar-Miri L.; Abbas Bukhari S.N.; Foroumadi A.; T&#xFC;yl&#xFC; K&#xFC;&#xE7;&#xFC;kkilin&#xE7; T.; Sharifzadeh M.; Khoobi M.; A review: Biologically active 3,4-heterocycle-fused coumarins. Eur J Med Chem  2021,212,113034","journal-title":"Eur J Med Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"5961","DOI":"10.1021\/acs.joc.2c00232","volume":"87","author":"Kielesi\u0144ski \u0141.","year":"2022","unstructured":"Kielesi\u0144ski \u0141.; Deperasi\u0144ska I.; Morawski O.; Vygranenko K.V.; Ouellette E.T.; Gryko D.T.; Polarized, V-shaped, and conjoined biscoumarins: From lack of dipole moment alignment to high brightness. J Org Chem  2022,87(9),5961-5975","journal-title":"J Org Chem"},{"key":"ref=63","doi-asserted-by":"publisher","DOI":"10.5772\/59982","author":"Matos M.J.","year":"2015","unstructured":"Matos M.J.; Santana L.; Uriarte E.; Abreu O.A.; Molina E.; Yordi E.G.; Coumarins \u2014 An Important Class of Phytochemicals. In: Phytochemicals - Isolation, Characterisation and Role in Human Health InTech  2015","journal-title":"In: Phytochemicals - Isolation, Characterisation and Role in Human Health InTech"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1002547","DOI":"10.3389\/fchem.2022.1002547","volume":"10","author":"Pisani L.","year":"2022","unstructured":"Pisani L.; Catto M.; Muncipinto G.; Nicolotti O.; Carrieri A.; Rullo M.; Stefanachi A.; Leonetti F.; Altomare C.; A twenty-year journey exploring coumarin-based derivatives as bioactive molecules. Front Chem  2022,10,1002547","journal-title":"Front Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"6","DOI":"10.33263\/BRIAC131.006","volume":"13","year":"2023","unstructured":"Cytotoxicity, antioxidant activity, molecular docking, and dynamics simulation analysis against SARS-CoV-2 M and N protein models of phytoconstituents of Micromelum minutum. Biointerface Res Appl Chem Fatema-Tuz-Zohora.; Mahtarin, R.; Ali, M. A.; Islam, M. J.; Sohrab, M. H.; Hasan, C. M.; Ahsan, M. 2023,13(1),6","journal-title":"Biointerface Res Appl Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1002\/slct.201601336","volume":"1","author":"Mu&#xF1;oz A.","year":"2016","unstructured":"Mu&#xF1;oz A.; Fonseca A.; Matos M.J.; Uriarte E.; Santana L.; Borges F.; Figueroa R.; Olea Azar C.; Evaluation of antioxidant and antitrypanosomal properties of a selected series of synthetic 3-carboxamidocoumarins. ChemistrySelect  2016,1(15),4957-4964","journal-title":"ChemistrySelect"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"112044","DOI":"10.1016\/j.ejmech.2020.112044","volume":"188","author":"Gao F.","year":"2020","unstructured":"Gao F.; Sun Z.; Kong F.; Xiao J.; Artemisinin-derived hybrids and their anticancer activity. Eur J Med Chem  2020,188,112044","journal-title":"Eur J Med Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.2174\/092986708786242877","volume":"15","author":"Musa M.","year":"2008","unstructured":"Musa M.; Cooperwood J.; Khan M.O.; A review of coumarin derivatives in pharmacotherapy of breast cancer. Curr Med Chem  2008,15(26),2664-2679","journal-title":"Curr Med Chem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"8897","DOI":"10.3390\/molecules27248897","volume":"27","author":"Dettori T.","year":"2022","unstructured":"Dettori T.; Sanna G.; Cocco A.; Serreli G.; Deiana M.; Palmas V.; Onnis V.; Pilia L.; Melis N.; Moi D.; Caria P.; Secci F.; Synthesis and antiproliferative effect of halogenated coumarin derivatives. Molecules  2022,27(24),8897","journal-title":"Molecules"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1080\/07391102.2020.1863263","volume":"40","author":"&#xD6;zdemir M.","year":"2022","unstructured":"&#xD6;zdemir M.; K&#xF6;ksoy B.; Ceyhan D.; Say\u0131n K.; Er&#xE7;a&#x11F; E.; Bulut M.; Yal&#xE7;\u0131n B.; Design and in silico study of the novel coumarin derivatives against SARS-CoV-2 main enzymes. J Biomol Struct Dyn  2022,40(11),4905-4920","journal-title":"J Biomol Struct Dyn"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"14140","DOI":"10.1002\/slct.201903607","volume":"4","author":"Hasan A.H.","year":"2019","unstructured":"Hasan A.H.; Amran S.I.; Saeed Hussain F.H.; Jaff B.A.; Jamalis J.; Molecular docking and recent advances in the design and development of cholinesterase inhibitor scaffolds: Coumarin hybrids. ChemistrySelect  2019,4(48),14140-14156","journal-title":"ChemistrySelect"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ejmech.2016.07.056","volume":"123","author":"Hassan M.Z.","year":"2016","unstructured":"Hassan M.Z.; Osman H.; Ali M.A.; Ahsan M.J.; Therapeutic potential of coumarins as antiviral agents. Eur J Med Chem  2016,123,236-255","journal-title":"Eur J Med Chem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1080\/14786419.2022.2110094","volume":"37","author":"Fobofou S.A.T.","year":"2023","unstructured":"Fobofou S.A.T.; Franke K.; Brandt W.; Manzin A.; Madeddu S.; Serreli G.; Sanna G.; Wessjohann L.A.; Bichromonol, a dimeric coumarin with anti-HIV activity from the stem bark of Hypericum roeperianum. Nat Prod Res  2023,37(12),1947-1953","journal-title":"Nat Prod Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1128\/JCM.02831-14","volume":"53","author":"Murphy D.G.","year":"2015","unstructured":"Murphy D.G.; Sablon E.; Chamberland J.; Fournier E.; Dandavino R.; Tremblay C.L.; Hepatitis C.; Hepatitis C virus genotype 7, a new genotype originating from central Africa. J Clin Microbiol  2015,53(3),967-972","journal-title":"J Clin Microbiol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3390\/antiox11050930","volume":"11","author":"Selim S.","year":"2022","unstructured":"Selim S.; Almuhayawi M.S.; Alharbi M.T.; Al Jaouni S.K.; Alharthi A.; Abdel-Wahab B.A.; Ibrahim M.A.R.; Alsuhaibani A.M.; Warrad M.; Rashed K.; Insights into the antimicrobial, antioxidant, anti-SARS-CoV-2 and cytotoxic activities of Pistacia lentiscus bark and phytochemical profile; in silico and in vitro study. Antioxidants  2022,11(5),930","journal-title":"Antioxidants"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ejmech.2019.01.037","volume":"166","author":"Hwu J.R.","year":"2019","unstructured":"Hwu J.R.; Huang W.C.; Lin S.Y.; Tan K.T.; Hu Y.C.; Shieh F.K.; Bachurin S.O.; Ustyugov A.; Tsay S.C.; Chikungunya virus inhibition by synthetic coumarin\u2013guanosine conjugates. Eur J Med Chem  2019,166,136-143","journal-title":"Eur J Med Chem"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"e03217","DOI":"10.1016\/j.heliyon.2020.e03217","volume":"6","author":"Mishra S.","year":"2020","unstructured":"Mishra S.; Pandey A.; Manvati S.; Coumarin: An emerging antiviral agent. Heliyon  2020,6(1),e03217","journal-title":"Heliyon"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"105424","DOI":"10.1016\/j.ejps.2020.105424","volume":"152","author":"Garg S.S.","year":"2020","unstructured":"Garg S.S.; Gupta J.; Sharma S.; Sahu D.; An insight into the therapeutic applications of coumarin compounds and their mechanisms of action. Eur J Pharm  Sci  2020,152,105424","journal-title":"Eur J Pharm  Sci"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"91","DOI":"10.5772\/intechopen.8976","author":"Bipat R.","year":"2020","unstructured":"Bipat R.; From rat poison to medicine: Medical applications of coumarin derivatives. In: Phytochemicals in Human Health IntechOpen  2020,91-104","journal-title":"In: Phytochemicals in Human Health IntechOpen"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2174\/1871523018666190625170802","volume":"19","author":"Jamalis J.","year":"2020","unstructured":"Jamalis J.; Yusof F.S.M.; Chander S.; Wahab R.A.; P Bhagwat D.; Sankaranarayanan M.; Almalki F.; Hadda T.B.; Psoralen derivatives: Recent advances of synthetic strategy and pharmacological properties. Antiinflamm Antiallergy Agents Med Chem  2020,19(3),222-239","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"500","DOI":"10.2174\/1389450116666150722141906","volume":"18","author":"Timson D.","year":"2017","unstructured":"Timson D.; Dicoumarol: A drug which hits at least two very different targets in vitamin k metabolism. Curr Drug Targets  2017,18(5),500-510","journal-title":"Curr Drug Targets"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3390\/molecules25061465","volume":"25","author":"Kasperkiewicz K.","year":"2020","unstructured":"Kasperkiewicz K.; Ponczek M.B.; Owczarek J.; Guga P.; Budzisz E.; Antagonists of Vitamin K\u2014Popular coumarin drugs and new synthetic and natural coumarin derivatives. Molecules  2020,25(6),1465","journal-title":"Molecules"},{"key":"ref=83","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.78023","author":"Lombardi N.","year":"2018","unstructured":"Lombardi N.; Crescioli G.; Vannacci A.; Real-world safety of anticoagulants. Anticoagulant Drugs  2018","journal-title":"Anticoagulant Drugs"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"803338","DOI":"10.3389\/fphar.2022.803338","volume":"13","author":"Heghes S.C.","year":"2022","unstructured":"Heghes S.C.; Vostinaru O.; Mogosan C.; Miere D.; Iuga C.A.; Filip L.; Safety profile of nutraceuticals rich in coumarins: An update. Front Pharmacol  2022,13,803338","journal-title":"Front Pharmacol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"9063","DOI":"10.3390\/molecules27249063","volume":"27","author":"Pitaro M.","year":"2022","unstructured":"Pitaro M.; Croce N.; Gallo V.; Arienzo A.; Salvatore G.; Antonini G.; Coumarin-induced hepatotoxicity: A narrative review. Molecules  2022,27(24),9063","journal-title":"Molecules"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.antiviral.2005.02.006","volume":"66","author":"M&#xE1;rquez N.","year":"2005","unstructured":"M&#xE1;rquez N.; Sancho R.; Bedoya L.; Alcam&#xED; J.; L&#xF3;pezp&#xE9;rez J.; Feliciano A.; Fiebich B.; Mu&#xF1;oz E.; Mesuol, a natural occurring 4-phenylcoumarin, inhibits HIV-1 replication by targeting the NF-&#x3BA;B pathway. Antiviral Res  2005,66(2-3),137-145","journal-title":"Antiviral Res"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"37349","DOI":"10.1074\/jbc.M401993200","volume":"279","author":"Sancho R.","year":"2004","unstructured":"Sancho R.; M&#xE1;rquez N.; G&#xF3;mez-Gonzalo M.; Calzado M.A.; Bettoni G.; Coiras M.T.; Alcam&#xED; J.; L&#xF3;pez-Cabrera M.; Appendino G.; Mu&#xF1;oz E.; Imperatorin inhibits HIV-1 replication through an Sp1-dependent pathway. J Biol Chem  2004,279(36),37349-37359","journal-title":"J Biol Chem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1053\/jhep.1996.v24.pm0008781315","volume":"24","author":"Huang R.","year":"1996","unstructured":"Huang R.; Chen C.C.; Huang Y.L.; Hsieh D.J.; Hu C.P.; Chen C.F.; Chang C.; Osthole increases glycosylation of hepatitis B surface antigen and suppresses the secretion of hepatitis B virus in vitro. Hepatology  1996,24(3),508-515","journal-title":"Hepatology"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"145102","DOI":"10.1016\/j.gene.2020.145102","volume":"762","author":"G&#xF3;mez J.","year":"2020","unstructured":"G&#xF3;mez J.; Albaiceta G.M.; Garc&#xED;a-Clemente M.; L&#xF3;pez-Larrea C.; Amado-Rodr&#xED;guez L.; Lopez-Alonso I.; Hermida T.; Enriquez A.I.; Herrero P.; Mel&#xF3;n S.; Alvarez-Arg&#xFC;elles M.E.; Boga J.A.; Rojo-Alba S.; Cuesta-Llavona E.; Alvarez V.; Lorca R.; Coto E.; Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome. Gene  2020,762,145102","journal-title":"Gene"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0960-894X(98)00713-6","volume":"9","author":"Xu Z.Q.","year":"1999","unstructured":"Xu Z.Q.; Hollingshead M.G.; Borgel S.; Elder C.; Khilevich A.; Flavin M.T.; In vivo anti-HIV activity of (+)-calanolide a in the hollow fiber mouse model. Bioorg Med Chem Lett  1999,9(2),133-138","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1021\/js980122d","volume":"87","author":"Newman R.A.","year":"1998","unstructured":"Newman R.A.; Chen W.; Madden T.L.; Pharmaceutical properties of related calanolide compounds with activity against human immunodeficiency virus. J Pharm Sci  1998,87(9),1077-1080","journal-title":"J Pharm Sci"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"745646","DOI":"10.3389\/fphar.2021.745646","volume":"12","author":"Li Z.","year":"2021","unstructured":"Li Z.; Wang F.; Liu Y.; Zhai D.; Zhang X.; Ying Q.; Jia M.; Xue X.; Meng J.; Li J.; Wu X.; Li M.; Coumarin derivative N6 as a novel anti-hantavirus infection agent targeting AKT. Front Pharmacol  2021,12,745646","journal-title":"Front Pharmacol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"736999","DOI":"10.1016\/j.aquaculture.2021.736999","volume":"543","author":"Wang H.","year":"2021","unstructured":"Wang H.; Hu Y.; Song D.; Shan L.; Liu L.; Synthesis and application of a potential therapeutic coumarin derivative against IHNV in aquaculture. Aquaculture  2021,543,736999","journal-title":"Aquaculture"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"737281","DOI":"10.1016\/j.aquaculture.2021.737281","volume":"545","author":"Hu Y.","year":"2021","unstructured":"Hu Y.; Shan L.; Liu H.; Liu L.; Chen J.; Highly efficient inhibition of infectious hematopoietic necrosis virus replication mediated by a novel synthesized coumarin derivative in vitro and in vivo. Aquaculture  2021,545,737281","journal-title":"Aquaculture"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.virusres.2019.01.009","volume":"263","author":"Liu L.","year":"2019","unstructured":"Liu L.; Hu Y.; Lu J.; Wang G.; An imidazole coumarin derivative enhances the antiviral response to spring viremia of carp virus infection in zebrafish. Virus Res  2019,263,112-118","journal-title":"Virus Res"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"100549","DOI":"10.1016\/j.xcrm.2022.100549","volume":"3","author":"Singh M.","year":"2022","unstructured":"Singh M.; de Wit E.; Antiviral agents for the treatment of COVID-19: Progress and challenges. Cell Rep Med  2022,3(3),100549","journal-title":"Cell Rep Med"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"p.e254","DOI":"10.1002\/mco2.254","volume":"4","author":"Xue Y","year":"2023","unstructured":"Xue Y; Mei H; Chen Y; Griffin JD; Liu Q; Weisberg E; Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS-CoV-2. MedComm  2023,4(3),p.e254","journal-title":"MedComm"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"152302","DOI":"10.1016\/j.imbio.2022.152302","volume":"228","author":"Jahirul Islam M.","year":"2023","unstructured":"Jahirul Islam M.; Nawal Islam N.; Siddik Alom M.; Kabir M.; Halim M.A.; A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sites. Immunobiology  2023,228(1),152302","journal-title":"Immunobiology"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41392-022-00884-5","volume":"7","author":"Yan W.","year":"2022","unstructured":"Yan W.; Zheng Y.; Zeng X.; He B.; Cheng W.; Structural biology of SARS-CoV-2: Open the door for novel therapies. Signal Transduct Target Ther  2022,7(1),26","journal-title":"Signal Transduct Target Ther"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/cells10040821","volume":"10","author":"Yadav R.","year":"2021","unstructured":"Yadav R.; Chaudhary J.K.; Jain N.; Chaudhary P.K.; Khanra S.; Dhamija P.; Sharma A.; Kumar A.; Handu S.; Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19. Cells  2021,10(4),821","journal-title":"Cells"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"955648","DOI":"10.3389\/fphar.2022.955648","volume":"13","author":"Liu X.H.","year":"2022","unstructured":"Liu X.H.; Cheng T.; Liu B.Y.; Chi J.; Shu T.; Wang T.; Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development. Front Pharmacol  2022,13,955648","journal-title":"Front Pharmacol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"819165","DOI":"10.3389\/fchem.2021.819165","volume":"9","author":"Lv Z.","year":"2022","unstructured":"Lv Z.; Cano K.E.; Jia L.; Drag M.; Huang T.T.; Olsen S.K.; Targeting SARS-CoV-2 proteases for COVID-19 antiviral development. Front Chem  2022,9,819165","journal-title":"Front Chem"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/B978-0-12-821618-7.00111-5","author":"Mukherjee R.","year":"2023","unstructured":"Mukherjee R.; Dikic I.; Proteases of SARS coronaviruses. Encyclopedia of Cell Biology  2023,930-941","journal-title":"Encyclopedia of Cell Biology"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"e202200327","DOI":"10.1002\/cbic.202200327","volume":"23","author":"Ullrich S.","year":"2022","unstructured":"Ullrich S.; Nitsche C.; SARS-CoV-2 papain-like protease: Structure, function and inhibition. ChemBioChem  2022,23(19),e202200327","journal-title":"ChemBioChem"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1002\/mco2.151","volume":"3","author":"Hu Q.","year":"2022","unstructured":"Hu Q.; Xiong Y.; Zhu G.; Zhang Y.; Zhang Y.; Huang P.; The SARS-CoV-2 main protease (Mpro): Structure, function, and emerging therapies for COVID-19. MedComm  2022,3(3),e151","journal-title":"MedComm"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1021\/acsinfecdis.0c00815","volume":"7","author":"Steuten K.","year":"2021","unstructured":"Steuten K.; Kim H.; Widen J.C.; Babin B.M.; Onguka O.; Lovell S.; Bolgi O.; Cerikan B.; Neufeldt C.J.; Cortese M.; Muir R.K.; Bennett J.M.; Geiss-Friedlander R.; Peters C.; Bartenschlager R.; Bogyo M.; Challenges for targeting SARS-CoV-2 proteases as a therapeutic strategy for COVID-19. ACS Infect Dis  2021,7(6),1457-1468","journal-title":"ACS Infect Dis"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2217\/fvl-2021-0335","volume":"18","author":"Wu J.","year":"2023","unstructured":"Wu J.; Chen Z.; Han X.; Chen Q.; Wang Y.; Feng T.; SARS-CoV-2 RNA-dependent RNA polymerase as a target for high-throughput drug screening. Future Virol  2023,18(1),51-62","journal-title":"Future Virol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s11845-022-03055-1","volume":"192","author":"Liu Y","year":"2023","unstructured":"Liu Y; Huang H.; ACE2, a drug target for COVID-19 treatment? Irish J Med Sci  2023,192(2),919-921","journal-title":"Irish J Med Sci"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41392-022-01084-x","volume":"7","author":"Keller C.","year":"2022","unstructured":"Keller C.; B&#xF6;ttcher-Friebertsh&#xE4;user E.; Lohoff M.; TMPRSS2, a novel host-directed drug target against SARS- COV-2. Signal Transduct Target Ther  2022,7(1),251","journal-title":"Signal Transduct Target Ther"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1515\/BC.2006.131","volume":"387","author":"Hamill P.","year":"2006","unstructured":"Hamill P.; Hudson D.; Kao R.Y.; Chow P.; Raj M.; Xu H.; Richer M.J.; Jean F.; Development of a red-shifted fluorescence-based assay for SARS-coronavirus 3CL protease: Identification of a novel class of anti-SARS agents from the tropical marine sponge Axinella corrugata. Biol Chem  2006,387(8),1063-1074","journal-title":"Biol Chem"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3109\/14756366.2014.1003215","volume":"31","author":"Park J.Y.","year":"2016","unstructured":"Park J.Y.; Ko J.A.; Kim D.W.; Kim Y.M.; Kwon H.J.; Jeong H.J.; Kim C.Y.; Park K.H.; Lee W.S.; Ryu Y.B.; Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV. J Enzyme Inhib Med Chem  2016,31(1),23-30","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.jiph.2020.09.002","volume":"13","author":"Chidambaram S.K.","year":"2020","unstructured":"Chidambaram S.K.; Ali D.; Alarifi S.; Radhakrishnan S.; Akbar I.; In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2. J Infect Public Health  2020,13(11),1671-1677","journal-title":"J Infect Public Health"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s11030-021-10230-6","volume":"26","author":"Abdizadeh R.","year":"2022","unstructured":"Abdizadeh R.; Hadizadeh F.; Abdizadeh T.; In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2. Mol Divers  2022,26(2),1053-1076","journal-title":"Mol Divers"},{"key":"ref=114","doi-asserted-by":"publisher","unstructured":"Lyndem, S.; Sarmah, S.; Das, S.; Roy, A.S. In silico screening of naturally occurring coumarin derivatives for the inhibition of the main protease of SARS-CoV-2. ChemRxiv, 2020, 1.","DOI":"10.26434\/chemrxiv.12234728.v1"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.sjbs.2020.11.038","volume":"28","author":"Chidambaram S.","year":"2021","unstructured":"Chidambaram S.; El-Sheikh M.A.; Alfarhan A.H.; Radhakrishnan S.; Akbar I.; Synthesis of novel coumarin analogues: Investigation of molecular docking interaction of SARS-CoV-2 proteins with natural and synthetic coumarin analogues and their pharmacokinetics studies. Saudi J Biol Sci  2021,28(1),1100-1108","journal-title":"Saudi J Biol Sci"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.3390\/molecules27072281","volume":"27","author":"Suleimen Y.M.","year":"2022","unstructured":"Suleimen Y.M.; Jose R.A.; Suleimen R.N.; Ishmuratova M.Y.; Toppet S.; Dehaen W.; Alsfouk A.A.; Elkaeed E.B.; Eissa I.H.; Metwaly A.M.; Isolation and in silico SARS-CoV-2 main protease inhibition potential of jusan coumarin, a new dicoumarin from Artemisia glauca. Molecules  2022,27(7),2281","journal-title":"Molecules"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"16970","DOI":"10.1039\/D1RA01989A","volume":"11","author":"Abdelmohsen U.R.","year":"2021","unstructured":"Abdelmohsen U.R.; Albohy A.; Abdulrazik B.S.; Bayoumi S.A.L.; Malak L.G.; Khallaf I.S.A.; Bringmann G.; Farag S.F.; Natural coumarins as potential anti-SARS-CoV-2 agents supported by docking analysis. RSC Advances  2021,11(28),16970-16979","journal-title":"RSC Advances"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41392-023-01511-7","volume":"8","author":"Peng Y.","year":"2023","unstructured":"Peng Y.; Chen S.; Wang Z.; Zhou Z.; Sun J.; Zhang G.; Li J.; Wang L.; Zhao J.; Tang X.X.; Wang D.Y.; Zhong N.; Dicoumarol is an effective post-exposure prophylactic for SARS-CoV-2 Omicron infection in human airway epithelium. Signal Transduct Target Ther  2023,8(1),242","journal-title":"Signal Transduct Target Ther"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"146400","DOI":"10.1016\/j.scitotenv.2021.146400","volume":"781","author":"Z&#xED;golo M.A.","year":"2021","unstructured":"Z&#xED;golo M.A.; Goytia M.R.; Poma H.R.; Rajal V.B.; Irazusta V.P.; Virtual screening of plant-derived compounds against SARS-CoV-2 viral proteins using computational tools. Sci Total Environ  2021,781,146400","journal-title":"Sci Total Environ"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"7704","DOI":"10.3390\/ijms23147704","volume":"23","author":"Piplani S.","year":"2022","unstructured":"Piplani S.; Singh P.; Winkler D.A.; Petrovsky N.; Potential COVID-19 therapies from computational repurposing of drugs and natural products against the SARS-CoV-2 helicase. Int J Mol Sci  2022,23(14),7704","journal-title":"Int J Mol Sci"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"798","DOI":"10.2174\/1385272820666151026224227","volume":"20","year":"2016","unstructured":"A. Kalam Khan F, P. Zambare S, D. Shinde S, N. Sangshetti J. Recent advances in the synthesis of coumarin derivatives via pechmann condensation. Curr Org Chem S. Zambare A 2016,20(7),798-828","journal-title":"Curr Org Chem"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2174\/1570179417666200116155704","volume":"17","author":"Lon&#x10D;ari\u0107 M.","year":"2020","unstructured":"Lon&#x10D;ari\u0107 M.; Su\u0161jenka M.; Molnar M.; An extensive study of coumarin synthesis via knoevenagel condensation in choline chloride based deep eutectic solvents. Curr Org Synth  2020,17(2),98-108","journal-title":"Curr Org Synth"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12032-022-01916-4","volume":"40","author":"Ratre P.","year":"2022","unstructured":"Ratre P.; Kulkarni S.; Das S.; Liang C.; Mishra P.K.; Thareja S.; Medicinal chemistry aspects and synthetic strategies of coumarin as aromatase inhibitors: An overview. Med Oncol  2022,40(1),41","journal-title":"Med Oncol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.2174\/1385272823666191121150047","volume":"23","author":"Francisco C.S.","year":"2020","unstructured":"Francisco C.S.; Francisco C.S.; Constantino A.F.; Neto &#xC1;.C.; Lacerda V.; Synthetic methods applied in the preparation of coumarin-based compounds. Curr Org Chem  2020,23(24),2722-2750","journal-title":"Curr Org Chem"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/inorganics10020023","volume":"10","author":"Szwaczko K.","year":"2022","unstructured":"Szwaczko K.; Coumarins synthesis and transformation via C\u2013H bond activation\u2014a review. Inorganics  2022,10(2),23","journal-title":"Inorganics"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"685","DOI":"10.2174\/1570179418666210301122322","volume":"18","author":"Jadhav N.K.","year":"2021","unstructured":"Jadhav N.K.; Kale B.R.; Alam M.S.; Gaikwad V.B.; Prasad V.; Kale R.R.; Synthesis and functionalization of coumarin-pyrazole scaffold: Recent development, challenges, and opportunities. Curr Org Synth  2021,18(7),685-710","journal-title":"Curr Org Synth"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10406638.2023.2235874","author":"Basavarajaiah S.M.","year":"2023","unstructured":"Basavarajaiah S.M.; Gunavanthrao Yernale N.; Punith Kumar M.; Rakesh B.; Review on contemporary synthetic recipes to access versatile coumarin heterocycles. Polycycl Aromat Compd  2023,1-25","journal-title":"Polycycl Aromat Compd"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1385272824666200120144305","volume":"24","author":"Molnar M.","year":"2020","unstructured":"Molnar M.; Lon&#x10D;ari\u0107 M.; Kova&#x10D; M.; Green chemistry approaches to the synthesis of coumarin derivatives. Curr Org Chem  2020,24(1),4-43","journal-title":"Curr Org Chem"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1021\/acs.jmedchem.9b01828","volume":"63","author":"Zhang L.","year":"2020","unstructured":"Zhang L.; Lin D.; Kusov Y.; Nian Y.; Ma Q.; Wang J.; von Brunn A.; Leyssen P.; Lanko K.; Neyts J.; de Wilde A.; Snijder E.J.; Liu H.; Hilgenfeld R.; &#x3B1;-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: structure-based design, synthesis, and activity assessment. J Med Chem  2020,63(9),4562-4578","journal-title":"J Med Chem"},{"key":"ref=130","first-page":"1385","volume":"12","author":"Parmar G.","year":"2022","unstructured":"Parmar G.; Shah A.; Shah S.; Seth A.K.; Identification of bioactive phytoconstituents from the plant Euphorbia Hirta as potential inhibitor of SARS-CoV-2: An in-silico approach. Biointerface Res Appl Chem  2022,12(2),1385-1396","journal-title":"Biointerface Res Appl Chem"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"115860","DOI":"10.1016\/j.bmc.2020.115860","volume":"29","author":"Amin S.A.","year":"2021","unstructured":"Amin S.A.; Banerjee S.; Ghosh K.; Gayen S.; Jha T.; Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain- like protease (PLpro) inhibitors. Bioorg Med Chem  2021,29,115860","journal-title":"Bioorg Med Chem"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1021\/acs.jcim.1c00449","volume":"61","author":"Cho E.","year":"2021","unstructured":"Cho E.; Rosa M.; Anjum R.; Mehmood S.; Soban M.; Mujtaba M.; Bux K.; Moin S.T.; Tanweer M.; Dantu S.; Pandini A.; Yin J.; Ma H.; Ramanathan A.; Islam B.; Mey A.S.J.S.; Bhowmik D.; Haider S.; Dynamic Profiling of &#x3B2;-Coronavirus 3CL M  protease ligand-binding sites. J Chem Inf Model  2021,61(6),3058-3073","journal-title":"J Chem Inf Model"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"Lipinski C.A.","year":"2001","unstructured":"Lipinski C.A.; Lombardo F.; Dominy B.W.; Feeney P.J.; Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3\u201325. 1. Adv Drug Deliv Rev  2001,46(1-3),3-26","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"104472","DOI":"10.1016\/j.arabjc.2022.104472","volume":"16","author":"Hosseini Nasab N.","year":"2023","unstructured":"Hosseini Nasab N.; Azimian F.; Kruger H.G.; Kim S.J.; Reaction of 3-Acetylcoumarin: From methods to mechanism. Arab J Chem  2023,16(2),104472","journal-title":"Arab J Chem"},{"key":"ref=135","first-page":"83","volume":"7","author":"Helmy M.M.","year":"2015","unstructured":"Helmy M.M.; Moustafa M.H.; Eldeab H.A.; Microwave-assisted synthesis of new series some acetyl coumarin derivatives and studying of some their pharmacological activities. J Pharma Sciences and Res  2015,7(2),83-88","journal-title":"J Pharma Sciences and Res"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1080\/00397911.2014.926374","volume":"44","author":"Vekariya R.H.","year":"2014","unstructured":"Vekariya R.H.; Patel H.D.; Recent advances in the synthesis of coumarin derivatives via knoevenagel condensation: A review. Synth Commun  2014,44(19),2756-2788","journal-title":"Synth Commun"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1515\/chem-2021-0024","volume":"19","author":"Abdellatiif M.H.","year":"2021","unstructured":"Abdellatiif M.H.; Ali A.; Ali A.; Hussien M.A.; Computational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-19. Open Chem  2021,19(1),245-264","journal-title":"Open Chem"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1136\/heartjnl-2020-317393","volume":"106","author":"Hippisley-Cox J.","year":"2020","unstructured":"Hippisley-Cox J.; Young D.; Coupland C.; Channon K.M.; Tan P.S.; Harrison D.A.; Rowan K.; Aveyard P.; Pavord I.D.; Watkinson P.J.; Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people. Heart  2020,106(19),1503-1511","journal-title":"Heart"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1016\/j.bmcl.2015.09.042","volume":"25","author":"Goswami R.","year":"2015","unstructured":"Goswami R.; Wohlfahrt G.; T&#xF6;rm&#xE4;kangas O.; Moilanen A.; Lakshminarasimhan A.; Nagaraj J.; Arumugam K.N.; Mukherjee S.; Chacko A.R.; Krishnamurthy N.R.; Jaleel M.; Palakurthy R.K.; Samiulla D.S.; Ramachandra M.; Structure-guided discovery of 2-aryl\/pyridin-2-yl-1H-indole derivatives as potent and selective hepsin inhibitors. Bioorg Med Chem Lett  2015,25(22),5309-5314","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"100135","DOI":"10.1074\/jbc.REV120.015980","volume":"296","author":"Fuentes-Prior P.","year":"2021","unstructured":"Fuentes-Prior P.; Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection. J Biol Chem  2021,296,100135","journal-title":"J Biol Chem"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1128\/JVI.02202-13","volume":"88","author":"Heurich A.","year":"2014","unstructured":"Heurich A.; Hofmann-Winkler H.; Gierer S.; Liepold T.; Jahn O.; P&#xF6;hlmann S.; TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol  2014,88(2),1293-1307","journal-title":"J Virol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.jmb.2006.11.078","volume":"366","author":"Lee T.W.","year":"2007","unstructured":"Lee T.W.; Cherney M.M.; Liu J.; James K.E.; Powers J.C.; Eltis L.D.; James M.N.G.; Crystal structures reveal an induced-fit binding of a substrate-like Aza-peptide epoxide to SARS coronavirus main peptidase. J Mol Biol  2007,366(3),916-932","journal-title":"J Mol Biol"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1021\/jm401712t","volume":"57","author":"B&#xE1;ez-Santos Y.M.","year":"2014","unstructured":"B&#xE1;ez-Santos Y.M.; Barraza S.J.; Wilson M.W.; Agius M.P.; Mielech A.M.; Davis N.M.; Baker S.C.; Larsen S.D.; Mesecar A.D.; X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases. J Med Chem  2014,57(6),2393-2412","journal-title":"J Med Chem"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1038\/s41467-019-10280-3","volume":"10","author":"Kirchdoerfer R.N.","year":"2019","unstructured":"Kirchdoerfer R.N.; Ward A.B.; Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. Nat Commun  2019,10(1),2342","journal-title":"Nat Commun"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.4067\/S0717-97072021000205220","volume":"66","author":"Z&#xE1;rraga O M.","year":"2021","unstructured":"Z&#xE1;rraga O M.; Darouch M.; Lisboa E.; Arroyo P P.; Miranda M A.; Synthesis of 6- tert -octyl and 6,8-di tert -butyl coumarins, two coumarins of biological interest. J Chil Chem Soc  2021,66(2),5220-5222","journal-title":"J Chil Chem Soc"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1055\/s-1998-2110","volume":"1998","author":"Lindoy L.F.","year":"1998","unstructured":"Lindoy L.F.; Mono- and diformylation of 4-substituted phenols: A new application of the duff reaction. Synthesis  1998,1998(7),1029-1032","journal-title":"Synthesis"},{"key":"ref=147","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1039\/p19940001823","author":"Aldred R.","year":"1994","unstructured":"Aldred R.; Johnston R.; Levin D.; Neilan J.; Magnesium-mediated ortho-specific formylation and formaldoximation of phenols. J Chem Soc Perkin  1994(13),1823","journal-title":"J Chem Soc Perkin"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"5521","DOI":"10.4067\/S0717-97072022000205521","volume":"67","author":"Salgado-Moran G.","year":"2022","unstructured":"Salgado-Moran G.; Cardona V.W.; Gerli-candia lorena, mendoza-huizar lh, abdizadeh t. identification of novel coumarin based compounds as potential inhibitors of the 3-chymotrypsin-like main protease of SARS-CoV-2 using dft, molecular docking and molecular dynamics simulation studies. J Chil Chem Soc  2022,67(2),5521-5536","journal-title":"J Chil Chem Soc"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"128918","DOI":"10.1016\/j.molstruc.2020.128918","volume":"1222","author":"Ait-Ramdane-Terbouche C.","year":"2020","unstructured":"Ait-Ramdane-Terbouche C.; Abdeldjebar H.; Terbouche A.; Lakhdari H.; Bachari K.; Roisnel T.; Hauchard D.; Crystal structure, chemical reactivity, kinetic and thermodynamic studies of new ligand derived from 4-hydroxycoumarin: Interaction with SARS-CoV-2. J Mol Struct  2020,1222,128918","journal-title":"J Mol Struct"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"13616","DOI":"10.1002\/slct.202103658","volume":"6","author":"Mohamed N.M.","year":"2021","unstructured":"Mohamed N.M.; Eltelbany R.F.A.; Synthetic coumarin derivatives as SARS-CoV-2 major protease inhibitors: Design, synthesis, bioevaluation and molecular docking. ChemistrySelect  2021,6(47),13616-13626","journal-title":"ChemistrySelect"},{"key":"ref=151","doi-asserted-by":"publisher","unstructured":"Su, H.X.; Yao, S.; Zhao, W.F.; Li, M.J.; Liu, J.; Shang, W.J.; Xie, H.; Ke, C.Q.; Hu, H.C.; Gao, M.N.; Yu, K.Q.; Liu, H.; Shen, J.S.; Tang, W.; Zhang, L.K.; Xiao, G.F.; Ni, L.; Wang, D.W.; Zuo, J.P.; Jiang, H.L.; Bai, F.; Wu, Y.; Ye, Y.; Xu, Y.C. Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients. Acta. Pharmacol. Sin., 2020, 41(9), 1167-1177.","DOI":"10.1038\/s41401-020-0483-6"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"119465","DOI":"10.1016\/j.ica.2020.119465","volume":"504","author":"Avdovi\u0107 E.H.","year":"2020","unstructured":"Avdovi\u0107 E.H.; Milanovi\u0107 &#x17D;.B.; &#x17D;ivanovi\u0107 M.N.; \u0160ekli\u0107 D.S.; Radojevi\u0107 I.D.; &#x10C;omi\u0107 L.R.; Trifunovi\u0107 S.R.; Ami\u0107 A.; Markovi\u0107 Z.S.; Synthesis, spectroscopic characterization, biological activity, DFT and molecular docking study of novel 4-hydroxycoumarine derivatives and corresponding palladium(II) complexes. Inorg Chim Acta  2020,504,119465","journal-title":"Inorg Chim Acta"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.saa.2018.01.023","volume":"195","author":"Avdovi\u0107 E.H.","year":"2018","unstructured":"Avdovi\u0107 E.H.; Milenkovi\u0107 D.; Dimitri\u0107 Markovi\u0107 J.M.; \u0110orovi\u0107 J.; Vukovi\u0107 N.; Vuki\u0107 M.D.; Jevti\u0107 V.V.; Trifunovi\u0107 S.R.; Poto&#x10D;\u0148&#xE1;k I.; Markovi\u0107 Z.; Synthesis, spectroscopic characterization (FT-IR, FT-Raman, and NMR), quantum chemical studies and molecular docking of 3-(1-(phenylamino)ethylidene)-chroman-2,4-dione. Spectrochim Acta A Mol Biomol Spectrosc  2018,195,31-40","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"35099","DOI":"10.1039\/D0RA07062A","volume":"10","author":"Milenkovi\u0107 D.A.","year":"2020","unstructured":"Milenkovi\u0107 D.A.; Dimi\u0107 D.S.; Avdovi\u0107 E.H.; Markovi\u0107 Z.S.; Several coumarin derivatives and their Pd(  ) complexes as potential inhibitors of the main protease of SARS-CoV-2, an in silico approach. RSC Advances  2020,10(58),35099-35108","journal-title":"RSC Advances"},{"key":"ref=155","first-page":"287","volume":"49","author":"Nestor J.O.","year":"1975","unstructured":"Nestor J.O.; Fesults of the failure to perform adequate preclinical studies before administering new drugs to humans. S Afr Med J  1975,49(8),287-290","journal-title":"S Afr Med J"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"173326","DOI":"10.1016\/j.ejphar.2020.173326","volume":"883","author":"Jin Z.","year":"2020","unstructured":"Jin Z.; Liu J.Y.; Feng R.; Ji L.; Jin Z.L.; Li H.B.; Drug treatment of coronavirus disease 2019 (COVID-19) in China. Eur J Pharmacol  2020,883(March),173326","journal-title":"Eur J Pharmacol"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1081\/SCC-120023987","volume":"33","author":"Deshmukh M.N.","year":"2003","unstructured":"Deshmukh M.N.; Burud R.; Baldino C.; Chan P.C.M.; Liu J.; A practical and environmentally friendly preparation of 3-carboxycoumarins. Synth Commun  2003,33(19),3299-3303","journal-title":"Synth Commun"},{"key":"ref=158","author":"Felix da Silva Gomes G.","year":"2022","unstructured":"Felix da Silva Gomes G.; Goes Camargo P.; de Santiago-Silva K.M.; Suzukawa H.T.; Sotero da Silva Ribeiro A.P.; Orsato A.; In silico approaches and in vitro assays identify a coumarin derivative as antiviral potential against SARS-CoV-2. J. Biomol. Struct. Dyn.  \n https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/07391102.2022.2140203\n2022"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673285609231220111556","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/225534\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673285609231220111556","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T19:51:03Z","timestamp":1735069863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/225534\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":158,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673285609231220111556","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-10-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}